Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Five-Marker Panel Helps Diagnose Lupus

By LabMedica International staff writers
Posted on 17 Jan 2012
A five-marker panel was designed to Rule-In Systemic Lupus Erythematosus (SLE) and Rule-Out other rheumatic diseases to help establish an accurate SLE diagnosis.

Called Avise SLE, the panel includes testing of antinuclear antibodies (ANA), anti-double stranded DNA antibodies (dsDNA), anti-mutated citrullinated vimentin antibodies (Avise MCV), EC4d, and BC4d. More...
The cell-bound complements rule-in SLE because of their increased performance over soluble complements, which help to accurately and consistently diagnose SLE.

ANA, dsDNA, and AntiMCV are measured using enzyme-linked immunosorbent assay (ELISA) whereas EC4d and BC4d are measured using flow cytometry. A negative result for ANA helps rule-out the possibility of SLE. A positive result for dsDNA rules-in SLE. AVISE MCV rules-out Rheumatoid Arthritis.

Exagen Diagnostics, Inc. (Albuquerque, NM, USA), a specialty focused molecular diagnostics laboratory that discovers, develops and markets proprietary tests for rheumatologists and gastroenterologists, launched the Avise SLE, which aids in the diagnosis of lupus (Systemic Lupus Erythematosus).

The serological and flow cytometric tests are performed using a standard blood specimen, and shipped to Exagen's specialized Clinical Laboratory Improvement Amendments (CLIA) registered, College of American Pathologists (CAP) certified laboratory for processing. The company provides kits, pays shipping costs, and returns test results in 7 business days

Related Links:

Exagen Diagnostics, Inc.




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.